Related references
Note: Only part of the references are listed.New perspectives for targeting RAF kinase in human cancer
Zoi Karoulia et al.
NATURE REVIEWS CANCER (2017)
Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer
Sylvain Delaunay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
New frontiers in translational control of the cancer genome
Morgan L. Truitt et al.
NATURE REVIEWS CANCER (2016)
Progenitor potential of nkx6.1-expressing cells throughout zebrafish life and during beta cell regeneration
Aurelie P. Ghaye et al.
BMC BIOLOGY (2015)
Optimization of Codon Translation Rates via tRNA Modifications Maintains Proteome Integrity
Danny D. Nedialkova et al.
CELL (2015)
A Dynamic Unfolded Protein Response Contributes to the Control of Cortical Neurogenesis
Sophie Laguesse et al.
DEVELOPMENTAL CELL (2015)
Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
Jenny E. Hernandez-Davies et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Annelien Verfaillie et al.
NATURE COMMUNICATIONS (2015)
Phosphorylation of Elp1 by Hrr25 Is Required for Elongator-Dependent tRNA Modification in Yeast
Wael Abdel-Fattah et al.
PLOS GENETICS (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Archaeal Elp3 catalyzes tRNA wobble uridine modification at C5 via a radical mechanism
Kiruthika Selvadurai et al.
NATURE CHEMICAL BIOLOGY (2014)
Cell type-specific mRNA purification by translating ribosome affinity purification (TRAP)
Myriam Heiman et al.
NATURE PROTOCOLS (2014)
Response of BRAF-Mutant Melanoma to BRAF Inhibition Is Mediated by a Network of Transcriptional Regulators of Glycolysis
Tiffany J. Parmenter et al.
CANCER DISCOVERY (2014)
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Cory M. Johannessen et al.
NATURE (2013)
Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation
F. Rapino et al.
CELL DEATH & DISEASE (2013)
Loss of a Conserved tRNA Anticodon Modification Perturbs Cellular Signaling
Boris Zinshteyn et al.
PLOS GENETICS (2013)
Biosynthesis and Function of Posttranscriptional Modifications of Transfer RNAs
Basma El Yacoubi et al.
ANNUAL REVIEW OF GENETICS, VOL 46 (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Speeding with control: codon usage, tRNAs, and ribosomes
Eva Maria Novoa et al.
TRENDS IN GENETICS (2012)
Activation of mTORC2 by Association with the Ribosome
Vittoria Zinzalla et al.
CELL (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of α-Tubulin
Catherine Creppe et al.
CELL (2009)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
Transcription impairment and cell migration defects in elongator-depleted cells: Implication for familial dysautonomia
Pierre Close et al.
MOLECULAR CELL (2006)
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma
EE Patton et al.
CURRENT BIOLOGY (2005)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Share Paper
